Survival after percutaneous coronary intervention for chronic total occlusion
Aurel Toma(Medical University of Vienna), Heinz Joachim Buettner(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Jan Minners(University College Hospital), Christian Valina(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Nikolaus Löffelhardt(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Michael Gick(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Mirosław Ferenc(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Florian Riede(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Franz–Josef Neumann(La Jolla Alcohol Research), Cathérine Gebhard(University Hospital of Zurich)
Cited by 32
Related Papers
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
|New England Journal of Medicine|2012|2.8k
Impact of sex and gender on COVID-19 outcomes in Europe
|Biology of Sex Differences|2020|1.4k
Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial
|The Lancet|2013|940
Prevention of Contrast Media–Associated Nephropathy
|Archives of Internal Medicine|2002|808
Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves
|European Heart Journal|2015|287